Description
Composition- Glimepiride 1 mg + Metformin 500 mg + Voglibose 0.3 mg
Mode of Action- Provides multi-target glycemic control by improving insulin action and reducing post-meal glucose spikes.
USPs- Stronger postprandial control; triple antidiabetic mechanism; effective bilayered therapy.
Prescribing Specialties- Diabetologist, General Physician
